Doctor Rocio Muniz-Anquela

Biomedical Research Institute of Murcia (IMIB-Arrixaca), El Palmar, Murcia (Spain)

Follow

Contributor content

Dapagliflozin preferentially reduces fibrosis biomarkers in chronic heart failure patients with high extracellular matrix remodeling activity

Presentation

Dapagliflozin preferentially reduces fibrosis biomarkers in chronic heart failure patients with high extracellular matrix remodeling activity

ESC 365 is supported by

novartis

Explore sponsored resources